Sage Journals: Discover world-class research

Retricted access

Research article

First published 2010-2

The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients

Asuman Orhan Varoglu, Erhan Varoglu, Rezzan Bayraktar [...]

Journal of Back and Musculoskeletal Rehabilitation

Retricted access

Other

First published 2007-06

Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis

G. Alanoglu, S. Kilbas, C. Arslan [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-11

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b

K. Baum, C. O'Leary, F. Coret Ferrer [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1996-06

Interferon beta treatment for multiple sclerosis: persisting questions

Donald E Goodkin

Multiple Sclerosis Journal

Retricted access

Research article

First published 2003-10

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy

Maria Trojano, Maria Liguori, Damiano Paolicelli [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1998-04

Interferon beta-1b injection site reactions and necroses

Ann Reed Gaines, Frederick Varricchio

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-4

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

J Kuhle, M Hardmeier, G Disanto [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-2

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

Gijsbert JA Nagtegaal, Christoph Pohl, Mike P Wattjes [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2004-04

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis

A John Petkau, Richard A White, George C Ebers [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2019-5

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b

Douglas S Goodin, Anthony T Reder, Anthony L Traboulsee [...]

Multiple Sclerosis Journal

Search results